Track market-moving stories before they get noisy

BURLINGTON, Mass.--(BUSINESS WIRE)--N-able, Inc. (NYSE: NABL), a global cybersecurity company delivering business resilience, today announced it has been named a Champion in the 2026 Omdia Global Managed Backup and Disaster Recovery (BDR) Leadership Matrix for the third consecutive year. The recognition comes as cyber recovery becomes a board-level priority, with organizations under growing pressure to protect critical data, recover faster, and maintain business continuity in the face of evolvi.

Posted by Defense World Staff on Jul 23rd, 2026

Bank of New York Mellon Corp lifted its position in shares of GoDaddy Inc. (NYSE:GDDY – Free Report) by 2.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 754,994 shares of the technology company’s stock after purchasing an additional 19,940 shares during the quarter. Bank of New York Mellon Corp owned 0.57% of GoDaddy worth $62,415,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in GDDY. Harel Insurance Investments & Financial Services Ltd. raised its position in shares of GoDaddy by 9.8% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 47,103 shares of the technology company’s stock worth $3,893,000 after acquiring an additional 4,223 shares during the period. Hillsdale Investment Management Inc. grew its position in shares of GoDaddy by 138.2% during the 1st quarter. Hillsdale Investment Management Inc. now owns 11,670 shares of the technology company’s stock valued at $965,000 after acquiring an additional 6,770 shares during the period. Principal Financial Group Inc. grew its position in shares of GoDaddy by 3.3% during the 1st quarter. Principal Financial Group Inc. now owns 181,582 shares of the technology company’s stock valued at $15,011,000 after acquiring an additional 5,880 shares during the period. J. Safra Sarasin Holding AG increased its stake in shares of GoDaddy by 19.2% in the 1st quarter. J. Safra Sarasin Holding AG now owns 11,464 shares of the technology company’s stock valued at $947,000 after purchasing an additional 1,847 shares in the last quarter. Finally, Procyon Advisors LLC raised its holdings in GoDaddy by 19.9% in the 1st quarter. Procyon Advisors LLC now owns 5,118 shares of the technology company’s stock worth $423,000 after purchasing an additional 850 shares during the period. 90.28% of the stock is owned by hedge funds and other institutional investors.

GoDaddy Price Performance NYSE:GDDY opened at $89.30 on Thursday. GoDaddy Inc. has a one year low of $71.59 and a one year high of $169.61. The stock has a market cap of $11.82 billion, a PE ratio of 14.13, a P/E/G ratio of 0.83 and a beta of 0.89. The company has a debt-to-equity ratio of 15.86, a quick ratio of 0.67 and a current ratio of 0.67. The stock has a 50 day moving average price of $85.86 and a 200 day moving average price of $89.67.

GoDaddy (NYSE:GDDY – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The technology company reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.53 by $0.07. GoDaddy had a return on equity of 366.90% and a net margin of 17.32%.The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same quarter in the previous year, the company posted $1.51 earnings per share. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. Equities research analysts expect that GoDaddy Inc. will post 7.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth A number of equities analysts have issued reports on the company. Wells Fargo & Company increased their price target on GoDaddy from $77.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of GoDaddy in a research note on Tuesday, June 16th. JPMorgan Chase & Co. decreased their target price on GoDaddy from $154.00 to $124.00 and set an “overweight” rating on the stock in a research report on Thursday, June 18th. Benchmark dropped their price target on shares of GoDaddy from $195.00 to $185.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Finally, UBS Group assumed coverage on shares of GoDaddy in a report on Tuesday, May 5th. They issued a “neutral” rating and a $100.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $118.43.

View Our Latest Research Report on GDDY

Insider Activity In other news, CAO Phontip Palitwanon sold 542 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $89.86, for a total value of $48,704.12. Following the completion of the sale, the chief accounting officer owned 19,995 shares of the company’s stock, valued at $1,796,750.70. This represents a 2.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Mark Mccaffrey sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $82.92, for a total transaction of $290,220.00. Following the sale, the chief financial officer owned 105,728 shares of the company’s stock, valued at $8,766,965.76. This represents a 3.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,751 shares of company stock valued at $1,480,228 in the last ninety days. 0.93% of the stock is currently owned by company insiders.

GoDaddy Company Profile (Free Report)

GoDaddy is a technology company that provides a suite of online services aimed primarily at small businesses, entrepreneurs and individuals looking to establish and grow an online presence. The company’s core activities include domain name registration and aftermarket services, a range of website hosting options, and tools for building, managing and promoting websites. Its product mix is designed to simplify the technical aspects of running a website so customers can focus on their businesses.

Product and service offerings span website builders and managed WordPress hosting, shared and dedicated hosting, e-commerce capabilities, email and productivity solutions, SSL certificates and site security tools, and online marketing and search engine optimization services.

Further Reading Five stocks we like better than GoDaddy Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for GoDaddy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoDaddy and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlamar Capital Management LLC Invests $2.35 Million in Fortinet, Inc. $FTNT

NEXT HEADLINE »Allspring Global Investments Holdings LLC Cuts Stock Position in AAR Corp. $AIR

Second quarter revenues of $3.04 billion, up 10.2% from 2025, with 10.0% organic revenue growth Second quarter reported diluted earnings per share ("EPS") of $2.84, up 15.0% from 2025; and adjusted diluted EPS of $3.12, up 19.1% from 2025 Full year 2026 revenues now expected to be between $11.95 billion and $12.05 billion Full year 2026 reported diluted EPS now expected to be between $9.97 and $10.17; and adjusted diluted EPS expected to be between $11.05 and $11.25 , /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the second quarter ended June 30, 2026.

"Our robust top- and bottom-line growth in the second quarter demonstrates focused execution of our strategy to connect people and providers to innovative testing and actionable insights that illuminate paths for better health," said Jim Davis, Chairman, CEO and President. "Revenues increased by over 10%, almost all from organic revenue growth across our physician, hospital and consumer channels, and adjusted diluted EPS grew over 19%. With strong growth and sustained demand for our diagnostic insights, we are again raising our full year guidance."

Recent Highlights:

Serving Customers and Delivering Innovations

Continued to advance our Co-Lab Solutions implementation and joint venture laboratory with Corewell Health in Michigan and developed new capabilities in kidney care through our collaboration with Fresenius Medical Care in the United States. Generated robust revenue growth through questhealth.com and our consumer, wearable and wellness partners. Grew revenues by double-digits in several areas of Advanced Diagnostics, including Quest AD-Detect® blood tests for Alzheimer's disease and advanced cardiometabolic and endocrine tests, including liver fibrosis testing. Granted New York State approval for our Haystack MRD® test and became the largest reference lab to utilize Flatiron Health's OncoEMR® Molecular Profiling Integration (MPI) platform for select cancer tests, including Haystack MRD, starting with a pilot with American Oncology Network (AON). Driving Operational Excellence

In the lab, extended automation solutions to improve quality and productivity in cervical cancer screening and front-end specimen processing to additional labs. Outside the lab, launched IntelliDraw™ to guide clinical staff of our physician customers through specimen collection, to enhance quality and the service experience.
Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

Change

2026

2025

Change

(dollars in millions, except per share data)

Reported:

Net revenues

$       3,043

$       2,761

10.2 %

$     5,938

$     5,413

9.7 %

Diagnostic Information Services
revenues

$       2,978

$       2,699

10.3 %

$     5,810

$     5,288

9.9 %

Revenue per requisition

(2.8) %

(2.1) %

Requisition volume

13.1 %

12.0 %

  Organic requisition volume

13.0 %

11.9 %

Operating income (a)

$          459

$          438

4.6 %

$         858

$         784

9.4 %

Operating income as a percentage of net
   revenues (a)

15.1 %

15.9 %

(0.8) %

14.4 %

14.5 %

(0.1) %

Net income attributable to Quest
Diagnostics (a)

$          320

$          282

13.4 %

$         572

$         502

13.9 %

Diluted EPS (a)

$         2.84

$         2.47

15.0 %

$        5.08

$        4.41

15.2 %

Cash provided by operations

$          597

$          544

9.7 %

$         875

$         858

1.9 %

Capital expenditures

$          138

$          108

27.0 %

$         252

$         225

12.1 %

Adjusted (a):

Operating income

$          502

$          466

7.8 %

$         949

$         872

8.8 %

Operating income as a percentage of net
revenues

16.5 %

16.9 %

(0.4) %

16.0 %

16.1 %

(0.1) %

Net income attributable to Quest
Diagnostics

$          350

$          298

17.3 %

$         631

$         549

14.9 %

Diluted EPS

$         3.12

$         2.62

19.1 %

$        5.62

$        4.83

16.4 %

(a) 

For further details impacting the year-over-year comparisons related to operating income, operating income as a percentage of net revenues, net income attributable to Quest Diagnostics, and diluted EPS, see note 2 of the financial tables attached below.

Updated Guidance for Full Year 2026

The company updates its full year 2026 guidance as follows:

Updated Guidance

Prior Guidance

Low

High

Low

High

Net revenues

$11.95 billion

$12.05 billion

$11.78 billion

$11.90 billion

Net revenues increase

8.3 %

9.2 %

6.8 %

7.8 %

Reported diluted EPS

$9.97

$10.17

$9.58

$9.78

Adjusted diluted EPS

$11.05

$11.25

$10.63

$10.83

Cash provided by operations

Approximately $1.80 billion

Approximately $1.75 billion

Capital expenditures

  Approximately $550 million

Approximately $550 million

Based on the favorable resolution of various tax contingencies in the second quarter, the full year adjusted effective tax rate is expected to be consistent with 2025.

Note on Non-GAAP Financial Measures

As used in this press release the term "reported" refers to measures under accounting principles generally accepted in the United States ("GAAP"). The term "adjusted" refers to non-GAAP operating performance measures that exclude special items such as restructuring and integration charges, amortization expense, excess tax benefits ("ETB") associated with stock-based compensation, gains and losses associated with changes in the carrying value of our strategic investments and other items.

Non-GAAP adjusted measures are presented because management believes those measures are useful adjuncts to GAAP results. Non-GAAP adjusted measures should not be considered as an alternative to the corresponding measures determined under GAAP. Management may use these non-GAAP measures to evaluate our performance period over period and relative to competitors, to analyze the underlying trends in our business, to establish operational budgets and forecasts and for incentive compensation purposes. We believe that these non-GAAP measures are useful to investors and analysts to evaluate our performance period over period and relative to competitors, as well as to analyze the underlying trends in our business and to assess our performance. The additional tables attached below include reconciliations of non-GAAP adjusted measures to GAAP measures.

Conference Call Information 

Quest Diagnostics will hold its quarterly conference call to discuss financial results beginning at 8:30 a.m. Eastern Time today.  The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, passcode: 7895081; or via live webcast on our website at www.QuestDiagnostics.com/investor.  We suggest participants dial in approximately 10 minutes before the call.

A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or, from approximately 10:30 a.m. Eastern Time on July 23, 2026 until midnight Eastern Time on August 6, 2026, by phone at 866-388-5361 for domestic callers or 203-369-0416 for international callers.  Anyone listening to the call is encouraged to read our periodic reports, on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About Quest Diagnostics

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com.

Forward Looking Statements

The statements in this press release which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, uncertain and volatile economic conditions, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government policies, including related to trade, and regulations, changing relationships with customers, payers, suppliers or strategic partners, acquisitions and other factors discussed in the company's most recently filed Annual Report on Form 10-K and in any of the company's subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the "Business," "Risk Factors," "Cautionary Factors that May Affect Future Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of those reports.

This earnings release, including the attached financial tables, is available online in the Newsroom section at www.QuestDiagnostics.com.

ADDITIONAL TABLES FOLLOW

Quest Diagnostics Incorporated and Subsidiaries
Consolidated Statements of Operations
For the Three and Six Months Ended June 30, 2026 and 2025
(in millions, except per share data)
(unaudited)

Three Months Ended
June 30,

Six Months Ended
June 30,

2026

2025

2026

2025

Net revenues

$    3,043

$    2,761

$  5,938

$    5,413

Operating costs and expenses and other operating income:

Cost of services

2,016

1,818

3,969

3,607

Selling, general and administrative

529

486

1,033

962

Amortization of intangible assets

38

39

75

78

Other operating expense (income), net

1

(20)

3

(18)

Total operating costs and expenses, net

2,584

2,323

5,080

4,629

Operating income

459

438

858

784

Other income (expense):

Interest expense, net

(63)

(67)

(126)

(134)

Other income, net

16

13

14

10

Total non-operating expense, net

(47)

(54)

(112)

(124)

Income before income taxes and equity in earnings of equity method
   investees

412

384

746

660

Income tax expense

(88)

(97)

(162)

(156)

Equity in earnings of equity method investees, net of taxes

10

9

14

27

Net income

334

296

598

531

Less: Net income attributable to noncontrolling interests

14

14

26

29

Net income attributable to Quest Diagnostics

$       320

$       282

$     572

$       502

Earnings per share attributable to Quest Diagnostics' common
   stockholders:

Basic

$      2.88

$      2.51

$    5.15

$      4.48

Diluted

$      2.84

$      2.47

$    5.08

$      4.41

Weighted average common shares outstanding:

Basic

111

112

110

112

Diluted

112

113

112

113

Quest Diagnostics Incorporated and Subsidiaries
Consolidated Balance Sheets
June 30, 2026 and December 31, 2025
(in millions, except per share data)
(unaudited)

June 30,
2026

December 31,
2025

Assets

Current assets:

Cash and cash equivalents

$                 626

$                420

Accounts receivable, net

1,666

1,408

Inventories

233

189

Prepaid expenses and other current assets

319

361

Total current assets

2,844

2,378

Property, plant and equipment, net

2,219

2,203

Operating lease right-of-use assets

678

657

Goodwill

9,112

8,945

Intangible assets, net

1,672

1,636

Investments in equity method investees

137

136

Other assets

277

270

Total assets

$            16,939

$           16,225

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable and accrued expenses

$              1,598

$             1,600

Current portion of long-term debt

10

504

Current portion of long-term operating lease liabilities

180

174

Total current liabilities

1,788

2,278

Long-term debt

5,632

5,167

Long-term operating lease liabilities

561

537

Other liabilities

1,059

957

Redeemable noncontrolling interest

80

80

Stockholders' equity:

Quest Diagnostics stockholders' equity:

Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2026 and
December 31, 2025; 162 shares issued as of both June 30, 2026 and December 31, 2025

2

2

Additional paid-in capital

2,374

2,381

Retained earnings

10,374

9,994

Accumulated other comprehensive loss

(62)

(27)

Treasury stock, at cost; 52 shares as of both June 30, 2026 and December 31, 2025

(5,172)

(5,180)

Total Quest Diagnostics stockholders' equity

7,516

7,170

Noncontrolling interests

303

36

Total stockholders' equity

7,819

7,206

Total liabilities and stockholders' equity

$            16,939

$           16,225

Quest Diagnostics Incorporated and Subsidiaries
Consolidated Statements of Cash Flows
For the Six Months Ended June 30, 2026 and 2025
(in millions)
(unaudited)

Six Months Ended June 30,

2026

2025

Cash flows from operating activities:

Net income

$              598

$              531

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

293

283

Provision for credit losses

3

2

Deferred income tax expense

46

8

Stock-based compensation expense

43

43

Other, net

14

26

Changes in operating assets and liabilities:

Accounts receivable

(259)

(115)

Accounts payable and accrued expenses

130

(11)

Income taxes payable

4

9

Other assets and liabilities, net

3

82

Net cash provided by operating activities

875

858

Cash flows from investing activities:

Business acquisitions, net of cash acquired

(38)

(17)

Capital expenditures

(252)

(225)

Other investing activities, net

4

3

Net cash used in investing activities

(286)

(239)

Cash flows from financing activities:

Proceeds from borrowings

494

400

Repayments of debt

(501)

(1,001)

Purchases of treasury stock

(102)

—

Exercise of stock options

81

42

Employee payroll tax withholdings on stock issued under stock-based compensation plans

(38)

(42)

Dividends paid

(184)

(174)

Distributions to noncontrolling interest partners

(22)

(29)

Other financing activities, net

(109)

(50)

Net cash used in financing activities

(381)

(854)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

(2)

5

Net change in cash and cash equivalents and restricted cash

206

(230)

Cash and cash equivalents and restricted cash, beginning of period

420

549

Cash and cash equivalents and restricted cash, end of period

$              626

$              319

Cash paid during the period for:

Interest

$              129

$              145

Income taxes

$              104

$              110

Notes to Financial Tables

1)  The computation of basic and diluted earnings per common share is as follows:

Three Months Ended
June 30,

Six Months Ended
June 30,

2026

2025

2026

2025

(in millions, except per share data)

Amounts attributable to Quest Diagnostics' common stockholders:

Net income attributable to Quest Diagnostics

$           320

$           282

$           572

$           502

Less: earnings allocated to participating securities

1

1

2

2

Earnings available to Quest Diagnostics' common stockholders - basic and
   diluted

$           319

$           281

$           570

$           500

Weighted average common shares outstanding - basic

111

112

110

112

Effect of dilutive securities:

Stock options and performance share units

1

1

2

1

Weighted average common shares outstanding - diluted

112

113

112

113

Earnings per share attributable to Quest Diagnostics' common
   stockholders:

Basic

$          2.88

$          2.51

$          5.15

$          4.48

Diluted

$          2.84

$          2.47

$          5.08

$          4.41

2)  The following tables reconcile reported GAAP results to non-GAAP adjusted results:

Three Months Ended June 30, 2026

(dollars in millions, except per share data)

Operating
income

Operating
income as a
percentage of
net revenues

Income tax
expense (e)

Equity in
earnings of
equity method
investees, net
of taxes

Net income
attributable to
Quest
Diagnostics

Diluted EPS

As reported

$                 459

15.1 %

$                  (88)

$                   10

$                 320

$                2.84

Restructuring and
integration charges (a)

4

0.2

(1)

—

3

0.04

Other charges (b)

1

—

1

—

2

0.02

Gains and losses on
investments (c)

—

—

—

(1)

(1)

(0.01)

Amortization expense

38

1.2

(10)

—

28

0.25

ETB

—

—

(2)

—

(2)

(0.02)

As adjusted

$                 502

16.5 %

$                (100)

$                     9

$                 350

$                3.12

Six Months Ended June 30, 2026

(dollars in millions, except per share data)

Operating
income

Operating
income as a
percentage of
net revenues

Income tax
expense (e)

Equity in
earnings of
equity method
investees, net
of taxes

Net income
attributable to
Quest
Diagnostics

Diluted EPS

As reported

$                 858

14.4 %

$                (162)

$                   14

$                 572

$                5.08

Restructuring and
integration charges (a)

11

0.2

(3)

—

8

0.08

Other charges (b)

5

0.1

—

—

5

0.05

Gains and losses on
investments (c)

—

—

(2)

6

4

0.04

Amortization expense

75

1.3

(19)

—

56

0.50

ETB

—

—

(14)

—

(14)

(0.13)

As adjusted

$                 949

16.0 %

$                (200)

$                   20

$                 631

$                5.62

Three Months Ended June 30, 2025

(dollars in millions, except per share data)

Operating
income

Operating
income as a
percentage of
net revenues

Income tax
expense (e)

Equity in
earnings of
equity method
investees, net
of taxes

Net income
attributable to
Quest
Diagnostics

Diluted EPS

As reported

$                 438

15.9 %

$                  (97)

$                     9

$                 282

$                2.47

Restructuring and
integration charges (a)

7

0.3

(2)

—

5

0.04

Other charges (b)

28

1.0

(6)

—

22

0.19

Gains and losses on
investments (c)

—

—

1

(1)

(2)

(0.01)

Other gains (d)

(46)

(1.7)

12

—

(34)

(0.30)

Amortization expense

39

1.4

(11)

—

28

0.25

ETB

—

—

(3)

—

(3)

(0.02)

As adjusted

$                 466

16.9 %

$                (106)

$                     8

$                 298

$                2.62

Six Months Ended June 30, 2025

(dollars in millions, except per share data)

Operating
income

Operating
income as a
percentage of
net revenues

Income tax
expense (e)

Equity in
earnings of
equity method
investees, net
of taxes

Net income
attributable to
Quest
Diagnostics

Diluted EPS

As reported

$                 784

14.5 %

$                (156)

$                   27

$                 502

$                4.41

Restructuring and
integration charges (a)

26

0.5

(7)

—

19

0.17

Other charges (b)

30

0.6

(6)

—

24

0.21

Gains and losses on
investments (c)

—

—

1

(1)

(2)

(0.01)

Other gains (d)

(46)

(0.9)

14

(8)

(40)

(0.36)

Amortization expense

78

1.4

(20)

—

58

0.51

ETB

—

—

(12)

—

(12)

(0.10)

As adjusted

$                 872

16.1 %

$                (186)

$                   18

$                 549

$                4.83

(a) 

For each of the three and six months ended June 30, 2026 and 2025, the pre-tax impact represents costs primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business.  The following table summarizes the pre-tax impact of restructuring and integration charges on our consolidated statements of operations:

Three Months Ended
June 30,

Six Months Ended
June 30,

2026

2025

2026

2025

(dollars in millions)

Cost of services

$               1

$               1

$               2

$               7

Selling, general and administrative

3

6

9

19

Operating income

$               4

$               7

$             11

$             26

(b) 

The three and six months ended June 30, 2026 and 2025 include losses associated with the change in the fair value of the contingent consideration accrual associated with previous acquisitions, recorded in other operating expense (income), net.  Additionally, for both the three and six months ended June 30, 2025, the pre-tax impact primarily represents a $24 million impairment charge on certain long-lived assets related to the exit of a business, recorded in other operating expense (income), net.

(c) 

For all periods presented, the pre-tax impact represents gains and losses associated with changes in the carrying value of our strategic investments, principally recorded in equity in earnings of equity method investees, net of taxes, and other income, net.

(d) 

The three and six months ended June 30, 2025 include a $46 million pre-tax gain, recorded in other operating expense (income), net, from a payroll tax credit under the Coronavirus Aid, Relief, and Economic Security Act associated with the retention of employees.  Additionally, the six months ended June 30, 2025 includes an $8 million gain, recorded in equity in earnings of equity method investees, net of taxes, representing a non-recurring gain related to a lease.

(e) 

For restructuring and integration charges, other gains/charges, gains and losses on investments, and amortization expense, income tax impacts, where recorded, were primarily calculated using combined statutory income tax rates of 25.5% for both 2026 and 2025.  No income tax impact was recorded on losses associated with the change in the fair value of the contingent consideration accrual associated with previous acquisitions.

3)

For both the three and six months ended June 30, 2026, we repurchased 0.5 million shares of our common stock for $100 million.  As of June 30, 2026, $1.3 billion remained available under our share repurchase authorization.

4)

The outlook for adjusted diluted EPS represents management's estimates for the full year 2026 before the impact of special items. Further impacts to earnings related to special items may occur throughout 2026. Additionally, the amount of ETB is dependent upon employee stock option exercises and our stock price, which are difficult to predict. The following table reconciles our 2026 outlook for diluted EPS under GAAP to our outlook for adjusted diluted EPS:

Low

High

Diluted EPS

$                                   9.97

$                                 10.17

Restructuring and integration charges (a)

0.14

0.14

Amortization expense (b)

0.99

0.99

Other charges (c)

0.10

0.10

Gains and losses on investments (d)

0.04

0.04

ETB

(0.19)

(0.19)

Adjusted diluted EPS

$                                 11.05

$                                 11.25

(a) 

Represents estimated pre-tax charges of $21 million primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business. Income tax benefits were primarily calculated using a combined statutory income tax rate of 25.5%.

(b) 

Represents estimated pre-tax amortization expenses of $149 million. Income tax benefits were primarily calculated using a combined statutory income tax rate of 25.5%.

(c) 

Principally represents estimated pre-tax net losses of $9 million associated with the increase in the fair value of the contingent consideration accrual associated with previous acquisitions. Such estimate is subject to the risks and uncertainties discussed in the "Forward Looking Statements" section above. No income tax benefits are recorded on the changes associated with the contingent consideration accrual.

(d) 

Income tax impacts were calculated using a combined statutory income tax rate of 25.5%.

SOURCE Quest Diagnostics

CompaniesJuly 23 (Reuters) - Quest Diagnostics (DGX.N), opens new tab on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped ​the company beat second-quarter estimates.

Shares of the New ‌Jersey-based company rose about 5% in premarket trading following the results.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

Here are the details:

Demand for the company's diagnostic testing ​services was strong across its physician, hospital and ​consumer channels, Quest said.

The results were "well above what ⁠was widely expected," Barclays analysts said.

Industry peer Labcorp (LH.N), opens new tab ​also raised its annual revenue and profit forecasts last quarter, ​after posting quarterly results above expectations as demand for diagnostic testing remained steady.

Quest Diagnostics reported second-quarter revenue of $3.04 billion, topping analysts' ​average estimate of $2.97 billion, according to data compiled by ​LSEG.

Adjusted profit was $3.12 per share, above expectations of $2.83 per share.

Revenue from ‌diagnostic ⁠information services, Quest's largest segment, increased 10.3% to $2.98 billion from a year ago, helped by a 13.1% increase in requisition volumes, including 13.0% organic volume growth.

Quest ​also reported double-digit ​growth in ⁠advanced diagnostics businesses, including Alzheimer's disease blood tests, advanced cardiometabolic tests and liver ​fibrosis testing.

The company expects 2026 revenue of $11.95 ​billion to $12.05 ⁠billion, above its prior forecast of $11.78 billion to $11.90 billion and analysts' estimate of $11.85 billion.

Quest expects adjusted profit of $11.05 ⁠to $11.25 ​per share in 2026, compared ​with its previous forecast of $10.63 to $10.83 per share. Analysts expect $10.76 per share.

Reporting ​by Sahil Pandey in Bengaluru; Editing by Shreya Biswas

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Harley-Davidson said it expects to sell more motorcycles this year than it previously expected to, after reporting strong North American sales in the second quarter.

WESTFORD, Mass.--(BUSINESS WIRE)--NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT), a leading provider of enterprise network observability, carrier service assurance, cybersecurity, and Distributed-Denial-of-Service (DDoS) protection solutions, plans to announce its first quarter fiscal year 2027 financial results for the period ended June 30, 2026, on Thursday, August 6, 2026, at approximately 7:30 a.m. ET. NETSCOUT will host a corresponding conference call and live webcast on the same day at 8:30 a.m. E.

USA: Index aktivity Chicago Fed v červnu vzrostl na -0,02 b.

COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, announced today that the Company will release its second quarter 2026 financial results on August 6, 2026. A webcast and conference call will be held that same day at 10:00 a.m. (Eastern Time) to review the Company's results. Webcast: The conference call will be available on the investor relations section of the Company'.

Posted by Defense World Staff on Jul 23rd, 2026

ABN Amro Investment Solutions reduced its stake in Sprouts Farmers Market, Inc. (NASDAQ:SFM – Free Report) by 22.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,867 shares of the company’s stock after selling 31,465 shares during the period. ABN Amro Investment Solutions owned approximately 0.11% of Sprouts Farmers Market worth $8,243,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of SFM. TD Private Client Wealth LLC increased its holdings in shares of Sprouts Farmers Market by 1,309.1% in the 4th quarter. TD Private Client Wealth LLC now owns 310 shares of the company’s stock worth $25,000 after acquiring an additional 288 shares during the period. Annis Gardner Whiting Capital Advisors LLC acquired a new position in Sprouts Farmers Market during the 1st quarter valued at about $25,000. Sound Income Strategies LLC bought a new stake in Sprouts Farmers Market during the fourth quarter worth approximately $27,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Sprouts Farmers Market in the 2nd quarter worth $29,000. Finally, Clearstead Advisors LLC lifted its holdings in shares of Sprouts Farmers Market by 72.7% in the fourth quarter. Clearstead Advisors LLC now owns 380 shares of the company’s stock valued at $30,000 after buying an additional 160 shares during the period.

Analyst Ratings Changes Several equities analysts have recently issued reports on the stock. Melius Research cut shares of Sprouts Farmers Market from a “hold” rating to a “sell” rating and set a $70.00 price objective on the stock. in a research note on Monday, April 6th. Evercore reissued an “outperform” rating on shares of Sprouts Farmers Market in a research report on Thursday, April 30th. Royal Bank Of Canada restated an “outperform” rating and issued a $114.00 target price on shares of Sprouts Farmers Market in a research note on Monday, June 1st. JPMorgan Chase & Co. upped their target price on Sprouts Farmers Market from $78.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Sprouts Farmers Market in a research note on Wednesday, June 24th. Seven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Sprouts Farmers Market currently has a consensus rating of “Hold” and a consensus target price of $96.62.

Get Our Latest Report on Sprouts Farmers Market

Sprouts Farmers Market Stock Down 1.0% Shares of NASDAQ SFM opened at $73.94 on Thursday. The firm’s 50-day simple moving average is $82.90 and its 200 day simple moving average is $78.00. The company has a market cap of $6.95 billion, a price-to-earnings ratio of 14.22, a price-to-earnings-growth ratio of 1.58 and a beta of 0.67. Sprouts Farmers Market, Inc. has a 12-month low of $64.75 and a 12-month high of $165.97. The company has a quick ratio of 0.42, a current ratio of 0.92 and a debt-to-equity ratio of 0.07.

Sprouts Farmers Market (NASDAQ:SFM – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.67 by $0.04. The business had revenue of $2.33 billion for the quarter, compared to analyst estimates of $2.32 billion. Sprouts Farmers Market had a net margin of 5.70% and a return on equity of 36.06%. Sprouts Farmers Market’s revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.81 earnings per share. Sprouts Farmers Market has set its FY 2026 guidance at 5.320-5.480 EPS and its Q2 2026 guidance at 1.320-1.360 EPS. On average, research analysts expect that Sprouts Farmers Market, Inc. will post 5.57 earnings per share for the current fiscal year.

Insider Activity In related news, insider Brandon F. Lombardi sold 406 shares of Sprouts Farmers Market stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $82.04, for a total value of $33,308.24. Following the sale, the insider owned 6,801 shares of the company’s stock, valued at approximately $557,954.04. This trade represents a 5.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jack Sinclair sold 10,788 shares of the business’s stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $84.87, for a total value of $915,577.56. Following the completion of the sale, the chief executive officer owned 269,980 shares in the company, valued at $22,913,202.60. The trade was a 3.84% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 45,310 shares of company stock worth $3,873,881 over the last three months. Corporate insiders own 1.30% of the company’s stock.

Sprouts Farmers Market Company Profile (Free Report)

Sprouts Farmers Market, Inc (NASDAQ: SFM) is a specialty grocery retailer focused on fresh, natural and organic foods. Headquartered in Phoenix, Arizona, the company operates stores designed to offer an open-market shopping experience, emphasizing quality produce sourced from regional farmers alongside organic pantry staples, dairy, meat and seafood. Sprouts’ product assortment also includes bulk foods, vitamins and supplements, a deli and prepared foods, reflecting its commitment to wellness and affordable healthy living.

Founded in 2002 by members of the Boney family, Sprouts began as a single farmers market in Chandler, Arizona.

Further Reading Five stocks we like better than Sprouts Farmers Market Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Sprouts Farmers Market Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sprouts Farmers Market and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEABN Amro Investment Solutions Buys 3,147 Shares of Phillips 66 $PSX

NEXT HEADLINE »AR Asset Management Inc. Acquires 2,266 Shares of AbbVie Inc. $ABBV

Posted by Defense World Staff on Jul 23rd, 2026

California Public Employees Retirement System lessened its position in Murphy USA Inc. (NYSE:MUSA – Free Report) by 15.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,347 shares of the specialty retailer’s stock after selling 7,766 shares during the period. California Public Employees Retirement System owned about 0.22% of Murphy USA worth $20,424,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its position in Murphy USA by 82.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 62 shares of the specialty retailer’s stock valued at $25,000 after buying an additional 28 shares in the last quarter. Huntington National Bank increased its holdings in shares of Murphy USA by 106.7% during the fourth quarter. Huntington National Bank now owns 62 shares of the specialty retailer’s stock worth $25,000 after buying an additional 32 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Murphy USA by 423.1% in the second quarter. EverSource Wealth Advisors LLC now owns 68 shares of the specialty retailer’s stock valued at $28,000 after acquiring an additional 55 shares during the last quarter. V Square Quantitative Management LLC bought a new position in shares of Murphy USA in the fourth quarter valued at approximately $29,000. Finally, WPG Advisers LLC boosted its holdings in shares of Murphy USA by 148.5% in the 4th quarter. WPG Advisers LLC now owns 82 shares of the specialty retailer’s stock worth $33,000 after acquiring an additional 49 shares in the last quarter. Institutional investors own 80.81% of the company’s stock.

Insider Buying and Selling In other news, SVP Keith A. Emery sold 517 shares of Murphy USA stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $574.49, for a total transaction of $297,011.33. Following the completion of the sale, the senior vice president owned 500 shares in the company, valued at $287,245. The trade was a 50.84% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Diane N. Landen sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $547.25, for a total transaction of $1,641,750.00. Following the sale, the director directly owned 53,841 shares of the company’s stock, valued at approximately $29,464,487.25. This trade represents a 5.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 46,225 shares of company stock worth $27,363,392. 9.02% of the stock is currently owned by company insiders.

Murphy USA Trading Up 1.2% MUSA stock opened at $618.22 on Thursday. The company has a market cap of $11.42 billion, a P/E ratio of 21.37, a PEG ratio of 1.97 and a beta of 0.30. Murphy USA Inc. has a twelve month low of $345.23 and a twelve month high of $636.04. The company has a quick ratio of 0.48, a current ratio of 0.83 and a debt-to-equity ratio of 3.24. The business has a fifty day moving average of $564.57 and a 200-day moving average of $496.66.

Murphy USA (NYSE:MUSA – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The specialty retailer reported $7.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.37 by $1.91. The business had revenue of $4.82 billion for the quarter, compared to analysts’ expectations of $4.70 billion. Murphy USA had a return on equity of 91.05% and a net margin of 2.81%.The firm’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter last year, the business earned $2.63 earnings per share. As a group, equities research analysts expect that Murphy USA Inc. will post 32.58 EPS for the current year.

Murphy USA Increases Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Monday, May 18th were paid a $0.64 dividend. This is a boost from Murphy USA’s previous quarterly dividend of $0.63. The ex-dividend date of this dividend was Monday, May 18th. This represents a $2.56 annualized dividend and a dividend yield of 0.4%. Murphy USA’s payout ratio is 8.85%.

Analyst Upgrades and Downgrades A number of research firms recently weighed in on MUSA. KeyCorp raised their price target on Murphy USA from $600.00 to $680.00 and gave the company an “overweight” rating in a report on Friday, June 12th. Weiss Ratings upgraded Murphy USA from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, June 30th. JPMorgan Chase & Co. began coverage on Murphy USA in a research note on Thursday, March 26th. They issued an “overweight” rating and a $539.00 target price for the company. Bank of America upped their price target on shares of Murphy USA from $600.00 to $625.00 and gave the stock a “neutral” rating in a research report on Friday, July 10th. Finally, Zacks Research lowered shares of Murphy USA from a “strong-buy” rating to a “hold” rating in a report on Monday, June 22nd. Six equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $585.11.

View Our Latest Report on MUSA

Murphy USA Company Profile (Free Report)

Murphy USA is a leading downstream marketer of gasoline, diesel and convenience store products in the United States. Headquartered in El Dorado, Arkansas, the company was originally established as part of Murphy Oil Corporation and was spun off as an independent public entity in 2013. Since its separation, Murphy USA has focused on retail fueling services and convenience offerings designed to deliver value and convenience to consumers.

The company’s primary operations center on two retail formats.

See Also Five stocks we like better than Murphy USA Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding MUSA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Murphy USA Inc. (NYSE:MUSA – Free Report).

Receive News & Ratings for Murphy USA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Murphy USA and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBroderick Brian C Boosts Position in Broadcom Inc. $AVGO

NEXT HEADLINE »Decker Wealth Management LLC Makes New $9.71 Million Investment in Alphabet Inc. $GOOG

Cleveland-Cliffs (CLF - Free Report) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.5 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +4.76%. A quarter ago, it was expected that this mining company would post a loss of $0.44 per share when it actually produced a loss of $0.4, delivering a surprise of +9.09%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Cleveland-Cliffs, which belongs to the Zacks Steel - Producers industry, posted revenues of $5.23 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.88%. This compares to year-ago revenues of $4.93 billion. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Cleveland-Cliffs shares have lost about 28.8% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for Cleveland-Cliffs?While Cleveland-Cliffs has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Cleveland-Cliffs was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.21 on $5.39 billion in revenues for the coming quarter and -$0.15 on $20.59 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Steel - Producers is currently in the top 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Nucor (NUE - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on July 27.

This steel company is expected to post quarterly earnings of $4.57 per share in its upcoming report, which represents a year-over-year change of +75.8%. The consensus EPS estimate for the quarter has been revised 6.3% higher over the last 30 days to the current level.

Nucor's revenues are expected to be $10.06 billion, up 19% from the year-ago quarter.

JERUSALEM--(BUSINESS WIRE)--Mobileye Global Inc. (Nasdaq: MBLY) (“Mobileye”) today released its financial results for the three months ended June 27, 2026. “The core business continued its strong momentum in Q2 as we focus our development and execution efforts on a number of advanced product launches in late 2026 and throughout 2027,” said Mobileye President and CEO Prof. Amnon Shashua. “Our foundation is robust and highly profitable, boosted by the recently enacted R&D Law which we expect.

Posted by Defense World Staff on Jul 23rd, 2026

Bank of New York Mellon Corp boosted its holdings in JFrog Ltd. (NASDAQ:FROG – Free Report) by 25.2% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,539,979 shares of the company’s stock after purchasing an additional 310,068 shares during the quarter. Bank of New York Mellon Corp owned about 1.27% of JFrog worth $72,271,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in FROG. Vanguard Group Inc. increased its stake in shares of JFrog by 4.0% in the 4th quarter. Vanguard Group Inc. now owns 9,505,832 shares of the company’s stock valued at $593,734,000 after acquiring an additional 362,654 shares in the last quarter. Whale Rock Capital Management LLC grew its holdings in JFrog by 82.2% in the fourth quarter. Whale Rock Capital Management LLC now owns 5,297,812 shares of the company’s stock worth $330,901,000 after purchasing an additional 2,389,415 shares during the period. Wasatch Advisors LP grew its holdings in JFrog by 187.4% in the first quarter. Wasatch Advisors LP now owns 4,156,033 shares of the company’s stock worth $195,043,000 after purchasing an additional 2,710,167 shares during the period. Price T Rowe Associates Inc. MD increased its stake in JFrog by 30.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,683,153 shares of the company’s stock valued at $167,590,000 after purchasing an additional 633,231 shares in the last quarter. Finally, Fiera Capital Corp increased its stake in JFrog by 37.5% in the fourth quarter. Fiera Capital Corp now owns 2,253,450 shares of the company’s stock valued at $140,750,000 after purchasing an additional 614,383 shares in the last quarter. 85.02% of the stock is owned by institutional investors and hedge funds.

Insider Activity at JFrog In other JFrog news, CEO Ben Haim Shlomi sold 15,000 shares of the business’s stock in a transaction dated Wednesday, July 8th. The shares were sold at an average price of $94.37, for a total value of $1,415,550.00. Following the transaction, the chief executive officer directly owned 4,577,237 shares in the company, valued at $431,953,855.69. The trade was a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Eduard Grabscheid sold 5,654 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $84.69, for a total transaction of $478,837.26. Following the transaction, the chief financial officer directly owned 209,658 shares of the company’s stock, valued at $17,755,936.02. This represents a 2.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 917,399 shares of company stock worth $73,629,102. 11.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades A number of equities analysts have recently issued reports on the stock. Raymond James Financial reissued an “outperform” rating on shares of JFrog in a research report on Wednesday. Benchmark started coverage on JFrog in a research note on Thursday, June 25th. They set a “buy” rating and a $100.00 price target on the stock. JPMorgan Chase & Co. increased their price target on JFrog from $68.00 to $76.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Morgan Stanley restated an “overweight” rating and set a $80.00 price objective on shares of JFrog in a report on Friday, May 8th. Finally, TD Cowen lifted their price target on shares of JFrog from $80.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, June 18th. Twenty-one equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $86.76.

Read Our Latest Report on FROG

JFrog Price Performance Shares of FROG stock opened at $79.68 on Thursday. The firm has a 50-day moving average of $82.82 and a 200-day moving average of $61.24. JFrog Ltd. has a one year low of $34.05 and a one year high of $99.22. The company has a market cap of $9.65 billion, a P/E ratio of -150.34 and a beta of 1.20.

JFrog (NASDAQ:FROG – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.05. The business had revenue of $153.98 million for the quarter, compared to analysts’ expectations of $147.45 million. JFrog had a negative net margin of 10.93% and a negative return on equity of 4.61%. The firm’s revenue for the quarter was up 25.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.20 earnings per share. JFrog has set its FY 2026 guidance at 0.930-0.970 EPS and its Q2 2026 guidance at 0.230-0.25 EPS. As a group, research analysts expect that JFrog Ltd. will post -0.15 earnings per share for the current fiscal year.

JFrog Company Profile (Free Report)

JFrog is a software company specializing in DevOps solutions designed to streamline the management, distribution and security of software binaries. Its core offering, JFrog Artifactory, serves as a universal artifact repository manager compatible with all major package formats, enabling development teams to store, version and share build artifacts across the software delivery pipeline. The company’s platform also includes tools for continuous integration and delivery (CI/CD), security scanning and release automation.

Among JFrog’s flagship products are JFrog Xray, a security and compliance scanning service that analyzes artifacts and dependencies for vulnerabilities; JFrog Pipelines, a CI/CD orchestration engine that automates build and release workflows; and JFrog Distribution, which accelerates the secure distribution of software releases to edge nodes and end users.

Featured Articles Five stocks we like better than JFrog Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for JFrog Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JFrog and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECommonwealth of Pennsylvania Public School Empls Retrmt SYS Increases Stake in NVIDIA Corporation $NVDA

NEXT HEADLINE »Microsoft Corporation $MSFT Shares Sold by Capital Planning LLC

The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of New York City, New York, U.S., January 21, 2021. REUTERS/Carlo... Purchase Licensing Rights, opens new tab Read more

SummaryCompaniesAnalysts estimate peptide industry is worth $2 billion to $3 billionFDA advisers will weigh whether peptides can be used for compoundingRulemaking to add peptides could take up to a year, former FDA official saysHims & Hers aims to offer peptide compounds, if approvedJuly 23 - Hims & Hers Health (HIMS.N), opens new tab is set to tap what analysts estimate could be ​a multi-billion-dollar market for peptides if U.S. regulators loosen manufacturing restrictions.

Hims, primarily known for its personalized treatments of conditions ranging from hair loss to ‌acne, is eyeing peptides not long after its attempts to create compounds of popular weight-loss drugs were smacked down by U.S. regulators. Peptides — used for everything from pain to muscle recovery to beauty — have been promoted by social media influencers and Health and Human Services Secretary Robert F. Kennedy Jr.

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

A U.S. Food and Drug Administration advisory committee meets this week to discuss whether the regulator should loosen ​compounding restrictions on seven peptides. If the restrictions are eased, research firm Needham & Co estimates the market could be as big as $3.3 billion, while Leerink analyst ​Michael Cherny estimated the market at $2.2 billion.

Peptides' wider use hinges on the FDA. Because Kennedy has said he has used them, ⁠some analysts say approval is likely regardless of the committee's decision.

If that happens, rulemaking that would allow compounders to make the products for patients could take up to ​a year, according to a former FDA official who requested anonymity.

Hims & Hers first announced it would pursue peptide therapies in 2025, when it purchased a manufacturing facility that ​can produce them. CEO Andrew Dudum has said the treatments would grow in popularity as demand for preventative health increases.

Peptide treatments are drugs built from short chains of amino acids, the same building blocks the body uses to make proteins.

Timing for the launch is uncertain. Dudum said in April that the company would not need to be the first U.S. company to offer peptides.

"If guidance changes, ​our clinical and compliance teams will assess what that means for our platform, and we will adjust accordingly," a Hims spokesperson said.

Hims owns one of the most ​popular compounding pharmacy businesses, which mix ingredients to create personalized treatments for patients. Its stock is notoriously volatile, with dramatic surges and equally staggering selloffs.

Over the last five months, the stock has ‌more than ⁠doubled, in part because the telehealth company entered into a partnership with Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab.

Compounded products are not reviewed for quality or efficacy by the FDA, unlike branded drugs. States also have authority over compounding.

ANALYSTS EXPECT FDA APPROVALAnalysts, legal experts and investors said they expect the committee to vote for looser regulations on compounding given the support from Kennedy and other industry-aligned members, even as FDA staffers in June challenged the evidence for peptide compounding.

The 14-member committee reviewing peptides has added seven people who operate or ​work for clinics or businesses selling peptide ​treatments.

Bill Holtz, a lawyer at Foley & Lardner, ⁠said Kennedy’s view will likely hold more weight in the review process for peptides than is typical for the agency under prior administrations.

“The law gives the Secretary of Health and Human Services the authority to determine what goes on that list," said ​Holtz.

A spokesperson for HHS did not respond to a Reuters request for comment.

The Alliance for Pharmacy Compounding, a trade organization, ​urged the FDA this month ⁠to allow compounding with regulatory oversight.

Kennedy, who has said he has used peptides, in April described a black market of unregulated products that still make their way into the United States.

PhRMA, the pharmaceutical industry trade organization, said in written comments to the FDA that the agency should not allow peptide compounding under Section 503A of the Federal Food, Drug, and ⁠Cosmetic Act, ​which allows for such combinations.

Ignacio Canto, founder of X-Square Capital, which owns less than 1% of Hims & ​Hers, said he expects Hims to launch the products quickly if it gets the go-ahead.

Options traders expect more volatility in Hims stock in coming weeks, with Trade Alert data showing shares could swing by as ​much as 14% in either direction by the end of the month.

Traders expect more volatility for Hims & Hers sharesReporting by Amina Niasse in New York; editing by Caroline Humer and David Gaffen

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Plus, the U.S. gives the president more muscular military options as he considers expanding the Iran war, and we go inside Taco Bell's rush to contain cyclospora.

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Semtech Corporation (NASDAQ: SMTC) (“Semtech”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/semtech-corporation/ Recently a securities fraud complaint was filed against Semtech on behalf of investors who purchased shares of the company's stock between October 10, 2024 and February 7, 2025 (the “Wrongdoing Period”). According.

23.7.2026 14:18

Depozitní sazba ECB (23. července):
aktuální hodnota: 2,25 %
očekávání trhu: 2,25 %
předchozí hodnota: 2,25 %

Refinanční sazba ECB (23. července):
aktuální hodnota: 2,4 %
očekávání trhu: 2,4 %
předchozí hodnota: 2,4 %

Zápůjční sazba ECB (23. července):
aktuální hodnota: 2,65 %
očekávání trhu: 2,65 %
předchozí hodnota: 2,65 %

Zdroj: Bloomberg

Michal Šnobl
Fio banka, a.s.
Prohlášení

23.7.2026 14:19

EUR/USD 1,1386 (euro oslabuje o 0,21 %)
USD/CZK 21,24 (dolar posiluje o 0,31 %)
EUR/CZK 24,19 (euro posiluje o 0,08 %)
GBP/CZK 28,31 (libra posiluje o 0,07 %)
CHF/CZK 26,02 (frank posiluje o 0,12 %)
PLN/CZK 5,5867 (zlotý posiluje o 0,15 %)

Zdroj: Reuters

Michal Šnobl
Fio banka, a.s.
Prohlášení

Posted by Defense World Staff on Jul 23rd, 2026

California Public Employees Retirement System raised its position in shares of Nebius Group N.V. (NASDAQ:NBIS – Free Report) by 380.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 240,388 shares of the company’s stock after purchasing an additional 190,388 shares during the quarter. California Public Employees Retirement System owned 0.10% of Nebius Group worth $24,943,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Parkside Financial Bank & Trust acquired a new position in Nebius Group during the fourth quarter valued at $25,000. Root Financial Partners LLC acquired a new position in shares of Nebius Group in the 4th quarter valued at about $26,000. SHP Wealth Management acquired a new position in shares of Nebius Group in the 4th quarter valued at about $26,000. Sound Income Strategies LLC lifted its position in shares of Nebius Group by 62.5% in the first quarter. Sound Income Strategies LLC now owns 260 shares of the company’s stock worth $27,000 after purchasing an additional 100 shares in the last quarter. Finally, Blue Trust Inc. boosted its holdings in shares of Nebius Group by 73.8% during the fourth quarter. Blue Trust Inc. now owns 332 shares of the company’s stock worth $28,000 after purchasing an additional 141 shares during the period. Hedge funds and other institutional investors own 21.90% of the company’s stock.

Nebius Group Stock Up 0.6% NBIS stock opened at $218.16 on Thursday. The firm has a market cap of $55.20 billion, a PE ratio of 70.37 and a beta of 4.10. Nebius Group N.V. has a 1 year low of $50.00 and a 1 year high of $299.86. The company has a fifty day simple moving average of $228.94 and a 200 day simple moving average of $155.95. The company has a current ratio of 8.33, a quick ratio of 8.33 and a debt-to-equity ratio of 1.16.

Nebius Group (NASDAQ:NBIS – Get Free Report) last posted its earnings results on Thursday, May 14th. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.81) by $0.58. Nebius Group had a net margin of 95.27% and a negative return on equity of 9.11%. The firm had revenue of $399.00 million for the quarter, compared to the consensus estimate of $375.13 million. Nebius Group’s revenue was up 684.0% compared to the same quarter last year. Sell-side analysts anticipate that Nebius Group N.V. will post -1.91 EPS for the current fiscal year.

Key Nebius Group News Here are the key news stories impacting Nebius Group this week:

Positive Sentiment: Robert W. Baird initiated coverage with an “outperform” rating and a $250 price target, adding another bullish analyst call to the stock’s recent momentum. Benzinga article Positive Sentiment: Northland Securities raised its price target to $410, reinforcing the view that Nebius may still have significant upside if AI infrastructure demand keeps accelerating. Northland Securities Boosts Nebius Group (NASDAQ:NBIS) Price Target to $410.00 Positive Sentiment: Freedom Capital Markets upgraded Nebius from hold to strong-buy, which further boosted sentiment around the stock. Zacks.com article Positive Sentiment: Multiple reports highlighted Nvidia’s 9.3% stake in Nebius as a strong vote of confidence in the company’s AI cloud strategy, helping extend the stock’s rally. CNBC article Positive Sentiment: Nebius also benefited from attention on its $775 million debt facility, which supports expansion without relying as heavily on equity dilution. Zacks article Neutral Sentiment: One article noted the chairman sold a small block of shares, but the transaction was limited and does not appear to change the broader bullish thesis. Motley Fool article Wall Street Analyst Weigh In Several research analysts have weighed in on the stock. Robert W. Baird assumed coverage on shares of Nebius Group in a research note on Wednesday. They issued an “outperform” rating and a $250.00 price objective on the stock. Wolfe Research assumed coverage on shares of Nebius Group in a research note on Thursday, April 16th. They set a “peer perform” rating for the company. Bank of America upped their price target on shares of Nebius Group from $240.00 to $280.00 and gave the stock a “buy” rating in a research note on Monday, June 8th. Freedom Capital upgraded Nebius Group from a “hold” rating to a “strong-buy” rating in a report on Monday. Finally, Wall Street Zen raised Nebius Group from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $222.15.

View Our Latest Report on NBIS

Insider Buying and Selling at Nebius Group In related news, CEO Arkadiy Volozh sold 46,627 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $235.45, for a total value of $10,978,327.15. Following the transaction, the chief executive officer directly owned 821,662 shares of the company’s stock, valued at approximately $193,460,317.90. This trade represents a 5.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CRO Marc Boroditsky sold 10,776 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $276.20, for a total value of $2,976,331.20. Following the completion of the transaction, the executive directly owned 26,886 shares in the company, valued at $7,425,913.20. The trade was a 28.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 668,405 shares of company stock worth $140,422,170 in the last 90 days.

Nebius Group Company Profile (Free Report)

Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company’s services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability.

See Also Five stocks we like better than Nebius Group Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Nebius Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nebius Group and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Sells 260,331 Shares of Hasbro, Inc. $HAS

NEXT HEADLINE »Bessemer Group Inc. Buys 1,121 Shares of Sandisk Corporation $SNDK

PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the second quarter of 2026 ended June 30, 2026 on Thursday, August 6, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: ir.dwavequantum.com.In conjunction with this annou.

WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Sarah Bast as Chief Marketing Officer.

I rate IREN Limited a Strong Buy with a $49 price target, implying 20% upside from current levels. My three modeled growth drivers are the 2026 AI Cloud revenue ramp, the additional 730MW planned for 2027, and lower financing costs from customer prepayments. Together, I estimate these drivers can produce approximately $2.03 in FWD non-GAAP adjusted EPS.

Posted by Defense World Staff on Jul 23rd, 2026

Bessemer Group Inc. grew its position in shares of Sandisk Corporation (NASDAQ:SNDK – Free Report) by 45.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,577 shares of the data storage provider’s stock after purchasing an additional 1,121 shares during the period. Bessemer Group Inc.’s holdings in Sandisk were worth $2,272,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. State Street Corp purchased a new position in Sandisk during the 3rd quarter valued at approximately $491,053,000. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Sandisk during the 3rd quarter worth approximately $297,293,000. Norges Bank purchased a new stake in shares of Sandisk during the 4th quarter worth approximately $518,889,000. Bank of America Corp DE bought a new position in shares of Sandisk during the 3rd quarter valued at approximately $190,425,000. Finally, AQR Capital Management LLC bought a new position in shares of Sandisk during the 3rd quarter valued at approximately $163,057,000.

Sandisk News Summary Here are the key news stories impacting Sandisk this week:

Positive Sentiment: Reports say memory prices are still surging, which supports expectations for stronger revenue and margins at Sandisk. Memory Prices Are Still Skyrocketing. Is the Next Rally for Micron, Sandisk, and SK Hynix Just Beginning? Positive Sentiment: Analysts and market commentators continue to highlight Sandisk as a beneficiary of AI-related NAND demand, enterprise SSD growth, and favorable pricing dynamics. Sandisk Trades at 8.3X Discounted P/E: Time to Buy the Stock? Positive Sentiment: UBS and other strategists said the recent selloff in AI and semiconductor names may be nearing exhaustion, which could help sentiment rebound further in Sandisk. UBS sees Broadcom, Sandisk, Oracle stocks rebounding: here’s why Positive Sentiment: Tuesday’s memory-stock rally and Morgan Stanley’s forecast for another big jump in memory prices reinforced the bullish setup for SNDK. Micron, Western Digital, and Sandisk Just Jumped 12% to 14%. Here’s the Forecast That Did It. Neutral Sentiment: Some coverage noted that the stock also saw profit-taking and broader market weakness at times, which can create short-term volatility even within the stronger trend. Why Is Sandisk Stock Falling on Wednesday? Analyst Upgrades and Downgrades A number of research analysts recently weighed in on SNDK shares. Sanford C. Bernstein raised their target price on shares of Sandisk from $1,700.00 to $3,000.00 and gave the company an “outperform” rating in a report on Monday, June 29th. Wells Fargo & Company upped their price target on shares of Sandisk from $1,250.00 to $1,620.00 and gave the company an “equal weight” rating in a research note on Wednesday. The Goldman Sachs Group reiterated a “buy” rating and set a $1,200.00 price objective on shares of Sandisk in a research report on Friday, May 1st. Arete Research raised shares of Sandisk from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. Finally, UBS Group set a $1,700.00 target price on shares of Sandisk in a report on Monday, May 4th. Two analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, Sandisk presently has a consensus rating of “Moderate Buy” and a consensus price target of $1,820.90.

View Our Latest Research Report on SNDK

Insider Activity at Sandisk In related news, insider Bernard Shek sold 600 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $2,088.00, for a total value of $1,252,800.00. Following the transaction, the insider owned 31,515 shares of the company’s stock, valued at $65,803,320. This trade represents a 1.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Alper Ilkbahar sold 2,000 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $1,756.58, for a total transaction of $3,513,160.00. Following the completion of the sale, the executive vice president directly owned 52,677 shares of the company’s stock, valued at approximately $92,531,364.66. This trade represents a 3.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 6,225 shares of company stock valued at $10,166,297. Company insiders own 0.21% of the company’s stock.

Sandisk Stock Performance Shares of NASDAQ SNDK opened at $1,599.27 on Thursday. Sandisk Corporation has a fifty-two week low of $40.10 and a fifty-two week high of $2,354.39. The company has a market cap of $236.84 billion, a price-to-earnings ratio of 55.59 and a beta of 4.74. The business’s 50 day moving average price is $1,748.90 and its 200-day moving average price is $1,075.37.

Sandisk (NASDAQ:SNDK – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The data storage provider reported $23.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $14.17 by $9.24. Sandisk had a return on equity of 44.06% and a net margin of 34.19%.The company had revenue of $5.95 billion during the quarter. During the same quarter in the previous year, the firm earned ($0.30) EPS. Sandisk’s revenue was up 251.0% compared to the same quarter last year. Sandisk has set its Q4 2026 guidance at 30.000-33.000 EPS. Sell-side analysts predict that Sandisk Corporation will post 64.52 earnings per share for the current year.

About Sandisk (Free Report)

SanDisk Corporation offers flash storage solutions. The Company designs, develops and manufactures data storage solutions in a range of form factors using flash memory, controller, firmware and software technologies. The Company operates through flash memory storage products segment. Its solutions include a range of solid state drives (SSD), embedded products, removable cards, universal serial bus (USB), drives, wireless media drives, digital media players, and wafers and components. It offers SSDs for client computing applications, which encompass desktop computers, notebook computers, tablets and other computing devices.

See Also Five stocks we like better than Sandisk Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding SNDK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sandisk Corporation (NASDAQ:SNDK – Free Report).

Receive News & Ratings for Sandisk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandisk and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINENebius Group N.V. $NBIS Holdings Boosted by California Public Employees Retirement System

NEXT HEADLINE »Zscaler, Inc. $ZS Shares Sold by California Public Employees Retirement System

Net Interest Margin Expansion Drives Record Quarterly Revenue of $126 million;
Strong Year-Over-Year Core Deposit and Business Loan Growth

Announces Plans to Resume Share Buybacks

HAUPPAUGE, N.Y., July 23, 2026 (GLOBE NEWSWIRE) -- Dime Commercial Bancshares, Inc. (NYSE: DCOM) (the “Company” or “Dime”), the parent company of Dime Commercial Bank (the “Bank”), today reported net income available to common stockholders of $33.0 million for the quarter ended June 30, 2026, or $0.75 per diluted common share, compared to net income available to common stockholders of $32.8 million, or $0.75 per diluted common share, for the quarter ended March 31, 2026 and net income available to common stockholders of $27.9 million for the quarter ended June 30, 2025, or $0.64 per diluted common share.

Adjusted net income available to common stockholders (non-GAAP) was $34.7 million and adjusted diluted EPS (non-GAAP) was $0.79 per share for the quarter ended June 30, 2026, compared to $0.74 per share for the quarter ended March 31, 2026 and $0.64 for the quarter ended June 30, 2025 (see "Non-GAAP Reconciliation" tables at the end of this news release).

Stuart H. Lubow, President and Chief Executive Officer (“CEO”) of the Company, stated, “Dime continues to execute on our growth plan and delivered record quarterly revenue. Second quarter results were marked by strong growth in business loans as our commercial banking teams are converting their robust pipelines. Recognizing the progress we have made in creating a high-quality balance sheet, Kroll Bond Rating Agency recently issued a “Positive” ratings outlook for Dime. Finally, and in recognition of our evolution into a commercial and private banking powerhouse, we recently completed our re-brand to “Dime Commercial Bank”.”

Capital Return: Mr. Lubow, stated, “In light of our strong capital position, lower CRE concentration levels, stress testing results, and improving profitability, we are pleased to announce that we expect to begin repurchasing our shares in the third quarter.”

Highlights for the Second Quarter of 2026 included:

Adjusted diluted EPS of $0.79 per share for the second quarter of 2026, compared to $0.64 per share for the second quarter of 2025;Total deposits increased $937.0 million on a year-over-year basis;Core deposits (excluding brokered and time deposits) increased $948.3 million on a year-over-year basis;Average non-interest-bearing deposits to average total deposits for the second quarter increased to 31.0%;Business loans grew $280.8 million on a linked quarter basis and $743.0 million on a year-over-year basis;The net interest margin increased to 3.28% for the second quarter of 2026 compared to 3.21% for the prior quarter;The efficiency ratio decreased to 51.2% for the second quarter of 2026 compared to 55.0% for second quarter of 2025;The adjusted efficiency ratio decreased to 49.9% for the second quarter of 2026 compared to 54.7% for the second quarter of 2025;The Company’s Tier 1 Common Equity Ratio increased to 11.99% at the end of the second quarter;The Company’s Consolidated CRE Concentration ratio was proactively managed lower to 352%; andNon-performing assets declined by 28% on a linked quarter basis and represented 0.46% of Total Assets.
Management’s Discussion of Quarterly Operating Results

Net Interest Income

Net interest income for the second quarter of 2026 was $115.2 million compared to $112.3 million for the first quarter of 2026 and $98.1 million for the second quarter of 2025. The Net Interest Margin for the second quarter of 2026 was 3.28% compared to 3.21% for the first quarter of 2026 and 2.98% for the second quarter of 2025.

Mr. Lubow commented, “We continue to have a significant loan repricing opportunity that we anticipate will continue through 2027. Additionally, growth in core deposits and business loans will benefit us over time as we continue to grow our customer base. Our substantial liquidity position, which includes $1.9 billion of cash, provides us with the flexibility to take advantage of lending opportunities as they arise. Dime’s asset liability management profile, which is underpinned by our cash position and a growing floating rate loan portfolio, positions us well for a variety of interest rate scenarios.”

Loan Portfolio

The ending weighted average rate (“WAR”) on the total loan portfolio was 5.36% at June 30, 2026, an 8-basis point increase compared to the ending WAR of 5.28% on the total loan portfolio at March 31, 2026.

Outlined below are loan balances and WARs for the quarter ended as indicated.

                   June 30, 2026 March 31, 2026 June 30, 2025 (Dollars in thousands) Balance WAR(1) Balance WAR(1) Balance WAR(1) Loans held for investment balances at period end:                Business loans(2) $3,645,194 6.32%$3,364,435 6.28%$2,902,170 6.65%One-to-four family residential and coop/condo apartment  1,075,904 5.04  1,047,920 4.97  998,677 4.85 Multifamily residential and residential mixed-use(3)(4)  3,113,647 4.48  3,249,582 4.47  3,693,481 4.48 Non-owner-occupied commercial real estate  2,770,751 5.14  2,840,817 5.05  3,128,453 5.12 Acquisition, development, and construction  90,476 7.10  100,574 7.41  141,755 8.28 Other loans  8,401 11.81  9,597 11.53  6,336 11.08 Loans held for investment $10,704,373 5.36%$10,612,925 5.28%$10,870,872 5.33% (1)WAR is calculated by aggregating interest based on the current loan rate from each loan in the category, adjusted for non-accrual loans, divided by the total balance of loans in the category.(2)Business loans include commercial and industrial loans, and owner-occupied commercial real estate loans. At June 30, 2025, business loans included balances related to Paycheck Protection Program (“PPP”) loans; no PPP loans were outstanding at June 30, 2026 or March 31, 2026.(3)Includes loans underlying multifamily cooperatives.(4)While the loans within this category are often considered "commercial real estate" in nature, multifamily and loans underlying cooperatives are reported separately from commercial real estate loans in order to emphasize the residential nature of the collateral underlying this significant component of the total loan portfolio.   Outlined below are the loan originations for the quarter ended as indicated.

          (Dollars in millions) Q2 2026 Q1 2026 Q2 2025Originations Excluding New Lines of Credit $255.3 $220.4 $227.3Originations Including New Lines of Credit  533.4  500.1  450.5           Deposits and Borrowed Funds

Period end total deposits (including mortgage escrow deposits) at June 30, 2026 were $12.68 billion, compared to $12.60 billion at March 31, 2026 and $11.74 billion at June 30, 2025.

Brokered deposits were $200.0 million at June 30, 2026, compared to $215.0 million at March 31, 2026 and $200.0 million at June 30, 2025. Total Federal Home Loan Bank advances were $385.0 million at June 30, 2026, compared to $435.0 million at March 31, 2026 and $508.0 million at June 30, 2025.

Non-Interest Income

Non-interest income was $11.3 million during the second quarter of 2026, $11.3 million during the first quarter of 2026, and $11.6 million during the second quarter of 2025. Excluding the fair value change in equity securities and loans held for sale, and loss (gain) on sale of securities, loans and other assets, non-interest income was $13.2 million during the second quarter of 2026, $11.7 million during the first quarter of 2026 and $11.4 million during the second quarter of 2025.

Non-Interest Expense

Total non-interest expense was $64.7 million during the second quarter of 2026, $62.8 million during the first quarter of 2026, and $60.3 million during the second quarter of 2025. Excluding the impact of the net loss (gain) on extinguishment of debt, amortization of other intangible assets and severance expense, adjusted non-interest expense was $64.1 million during the second quarter of 2026, $63.4 million during the first quarter of 2026, and $59.9 million during the second quarter of 2025 (see “Non-GAAP Reconciliation” tables at the end of this news release).

The ratio of non-interest expense to average assets was 1.74% during the second quarter of 2026, compared to 1.68% during the linked quarter and 1.72% during the second quarter of 2025. Excluding the impact of the net loss (gain) on extinguishment of debt, amortization of other intangible assets and severance expense, the ratio of adjusted non-interest expense to average assets was 1.72% during the second quarter of 2026, 1.69% during the first quarter of 2026, and 1.71% during the second quarter of 2025 (see “Non-GAAP Reconciliation” tables at the end of this news release).

The efficiency ratio was 51.2% during the second quarter of 2026, compared to 50.8% during the linked quarter and 55.0% during the second quarter of 2025. Excluding the impact of loss (gain) on sale of securities, loans and other assets, fair value change in equity securities and loans held for sale, severance expense, net loss (gain) on extinguishment of debt, and amortization of other intangible assets, the adjusted efficiency ratio was 49.9% during the second quarter of 2026, compared to 51.2% during the linked quarter and 54.7% during the second quarter of 2025 (see “Non-GAAP Reconciliation” tables at the end of this news release).

Mr. Lubow commented, “Our organic growth strategy is paying dividends as evidenced by a decline in the core efficiency ratio to below 50% for the second quarter. Growth in revenues is anticipated to continue to drive the efficiency ratio lower in the years ahead.”

Income Tax Expense

Income tax expense was $13.1 million during the second quarter of 2026, $13.9 million during the first quarter of 2026, and $10.5 million during the second quarter of 2025. The effective tax rate for the second quarter of 2026 was 27.3%, compared to 28.7% for the first quarter of 2026 and 26.1% for the second quarter of 2025.

Credit Quality

Non-performing assets were $69.0 million at June 30, 2026, compared to $95.6 million at March 31, 2026 and $53.2 million at June 30, 2025.

A credit loss provision of $13.9 million was recorded during the second quarter of 2026, compared to $12.3 million during the first quarter of 2026, and $9.2 million during the second quarter of 2025.

Capital Management

Stockholders’ equity increased $23.5 million to $1.52 billion at June 30, 2026, compared to $1.50 billion at March 31, 2026.

The Company’s and the Bank’s regulatory capital ratios continued to be in excess of all applicable regulatory requirements as of June 30, 2026. All risk-based regulatory capital ratios increased during the second quarter of 2026.

Dividends per common share were $0.25 during the second quarter of 2026 and the first quarter of 2026, respectively.

Book value per common share was $31.79 at June 30, 2026 compared to $31.33 at March 31, 2026.

Tangible common book value per share (which represents common equity less goodwill and other intangible assets, divided by the number of shares outstanding) was $28.21 at June 30, 2026 compared to $27.73 at March 31, 2026 (see “Non-GAAP Reconciliation” tables at the end of this news release).

Earnings Call Information

The Company will conduct a conference call at 8:30 a.m. (ET) on Thursday, July 23, 2026, during which CEO Lubow will discuss the Company’s second quarter 2026 financial performance, with a question-and-answer session to follow.

Participants may access the conference call via webcast using this link: https://edge.media-server.com/mmc/p/kjwp3pui. To participate via telephone, please register in advance using this link: https://register-conf.media-server.com/register/BI0e414999c97e4bf0bc9fe67d53be989f. Upon registration, all telephone participants will receive a one-time confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call. All participants are encouraged to dial-in 10 minutes prior to the start time.

A replay of the conference call and webcast will be available on-demand for 12 months at https://edge.media-server.com/mmc/p/kjwp3pui.

ABOUT DIME COMMERCIAL BANCSHARES, INC.
Dime Commercial Bancshares, Inc. is the holding company for Dime Commercial Bank, a New York State-chartered trust company with approximately $15 billion in assets and the number one deposit market share on Greater Long Island (1).

(1)Aggregate deposit market share for Kings, Queens, Nassau & Suffolk counties for commercial banks with less than $20 billion in assets.   This news release contains a number of forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements may be identified by use of words such as “annualized," “anticipate," "believe," “continue,” "could," "estimate," "expect," "intend," “likely,” "may," "outlook," "plan," "potential," "predict," "project," "should," "will," "would" and similar terms and phrases, including references to assumptions. Any forward-looking statements presented herein are made only as of the date of this release, and the Company does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise, except as may be required by law.

Forward-looking statements are based upon various assumptions and analyses made by the Company in light of management's experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate under the circumstances. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors (many of which are beyond the Company's control) that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Accordingly, you should not place undue reliance on such statements. Factors that could affect our results include, without limitation, the following: the timing and occurrence or non-occurrence of events may be subject to circumstances beyond the Company’s control; there may be increases in competitive pressure among financial institutions or from non-financial institutions; changes in the interest rate environment may affect demand for our products and reduce interest margins and the value of our investments; changes in government monetary or fiscal policies and actions may adversely affect our customers, cost of credit and overall result of operations; changes in deposit flows, the cost of funds, loan demand or real estate values may adversely affect the business of the Company; changes in the quality and composition of the Company’s loan or investment portfolios or unanticipated or significant increases in loan losses may negatively affect the Company’s financial condition or results of operations; changes in accounting principles, policies or guidelines may cause the Company’s financial condition to be perceived differently; changes in corporate and/or individual income tax laws may adversely affect the Company's financial condition or results of operations; general socio-economic conditions, public health emergencies, international conflict, inflation, tariffs, and recessionary pressures, either nationally or locally in some or all areas in which the Company conducts business, or conditions in the securities markets or the banking industry may be less favorable than the Company currently anticipates and may adversely affect our customers, our financial results and our operations; legislation or regulatory changes may adversely affect the Company’s business; technological changes may be more difficult or expensive than the Company anticipates; there may be failures or breaches of information technology security systems; success or consummation of new business initiatives may be more difficult or expensive than the Company anticipates; there may be difficulties or unanticipated expense incurred in the consummation of new business initiatives or the integration of any acquired entities; and litigation or other matters before regulatory agencies, whether currently existing or commencing in the future, may delay the occurrence or non-occurrence of events longer than the Company anticipates. For discussion of these and other risks that may cause actual results to differ from expectations, please refer to the sections entitled “Forward-Looking Statements” and “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and updates set forth in the Company’s subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Contact: Avinash Reddy Senior Executive Vice President – Chief Operating Officer and Chief Financial Officer 718-782-6200 extension 5909  DIME COMMERCIAL BANCSHARES, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
(In thousands)            June 30, March 31, December 31,  2026  2026  2025 Assets:         Cash and due from banks $1,934,594  $2,059,618  $2,353,966 Securities available-for-sale, at fair value  895,251   838,219   797,935 Securities held-to-maturity  706,606   647,842   618,901 Loans held for sale  1,862   38,225   1,989 Loans held for investment, net:         Business loans(1)  3,645,194   3,364,435   3,240,600 One-to-four family residential and coop/condo apartment  1,075,904   1,047,920   1,035,983 Multifamily residential and residential mixed-use(2)(3)  3,113,647   3,249,582   3,424,565 Non-owner-occupied commercial real estate  2,770,751   2,840,817   2,933,287 Acquisition, development and construction  90,476   100,574   117,215 Other loans  8,401   9,597   6,558 Allowance for credit losses  (104,963)  (100,673)  (97,372)Total loans held for investment, net  10,599,410   10,512,252   10,660,836 Premises and fixed assets, net  30,570   30,580   31,255 Restricted stock  61,167   63,659   67,197 BOLI  417,459   404,657   401,163 Goodwill  155,797   155,797   155,797 Other intangible assets  2,534   2,729   2,938 Operating lease assets  36,830   39,551   42,876 Derivative assets  70,545   70,811   76,315 Accrued interest receivable  56,282   57,690   55,572 Other assets  74,046   77,873   74,891 Total assets $15,042,953  $14,999,503  $15,341,631 Liabilities:         Non-interest-bearing checking (excluding mortgage escrow deposits) $3,946,965  $3,777,787  $3,915,081 Interest-bearing checking  1,140,667   1,066,620   1,178,281 Savings (excluding mortgage escrow deposits)  1,621,056   1,701,899   1,777,143 Money market  4,853,645   4,874,544   4,806,572 Certificates of deposit  1,068,824   1,089,893   1,117,118 Deposits (excluding mortgage escrow deposits)  12,631,157   12,510,743   12,794,195 Non-interest-bearing mortgage escrow deposits  45,980   88,267   47,051 Interest-bearing mortgage escrow deposits  —   —   — Total mortgage escrow deposits  45,980   88,267   47,051 Total deposits (including mortgage escrow deposits)  12,677,137   12,599,010   12,841,246 FHLBNY advances  385,000   435,000   508,000 Subordinated debt, net  231,186   231,058   272,503 Derivative cash collateral  61,790   57,630   52,400 Operating lease liabilities  39,626   42,431   45,729 Derivative liabilities  69,631   69,305   73,573 Other liabilities  58,127   68,099   72,411 Total liabilities  13,522,497   13,502,533   13,865,862 Stockholders' equity:         Preferred stock, Series A  116,569   116,569   116,569 Common stock  462   462   462 Additional paid-in capital  622,636   622,415   623,041 Retained earnings  898,089   876,133   854,167 Accumulated other comprehensive loss ("AOCI"), net of deferred taxes  (31,573)  (33,019)  (31,468)Unearned equity awards  (17,590)  (15,803)  (8,661)Treasury stock, at cost  (68,137)  (69,787)  (78,341)Total stockholders' equity  1,520,456   1,496,970   1,475,769 Total liabilities and stockholders' equity $15,042,953  $14,999,503  $15,341,631  (1)Business loans include commercial and industrial loans, and owner-occupied commercial real estate loans.(2)Includes loans underlying multifamily cooperatives.(3)While the loans within this category are often considered "commercial real estate" in nature, multifamily and loans underlying cooperatives are here reported separately from commercial real estate loans in order to emphasize the residential nature of the collateral underlying this significant component of the total loan portfolio. DIME COMMERCIAL BANCSHARES, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands except share and per share amounts)                  Three Months Ended Six Months Ended  June 30, March 31, June 30, June 30, June 30,  2026  2026  2025 2026  2025Interest income:               Loans $143,892  $142,090  $145,448 $285,982  $288,153Securities  14,518   12,788   11,353  27,306   22,676Other short-term investments  16,840   18,522   10,749  35,362   18,586Total interest income  175,250   173,400   167,550  348,650   329,415Interest expense:               Deposits and escrow  52,171   52,364   60,181  104,535   118,255Borrowed funds  7,351   8,300   8,354  15,651   16,735Derivative cash collateral  542   485   918  1,027   2,115Total interest expense  60,064   61,149   69,453  121,213   137,105Net interest income  115,186   112,251   98,097  227,437   192,310Provision for credit losses  13,875   12,313   9,221  26,188   18,847Net interest income after provision  101,311   99,938   88,876  201,249   173,463Non-interest income:               Service charges and other fees  6,483   5,730   4,642  12,213   9,285Title fees  187   142   118  329   216Loan level derivative income  535   472   942  1,007   1,003BOLI income  5,038   4,558   4,186  9,596   8,179Gain on sale of Small Business Administration ("SBA") loans  196   —   387  196   469Gain on sale of residential loans  49   72   50  121   82Fair value change in equity securities and loans held for sale  38   (38)  83  —   101Gain on securities  —   —   149  —   149Loss on sale of loans and other assets  (2,000)  (320)  —  (2,320)  —Other  740   730   1,038  1,470   1,744Total non-interest income  11,266   11,346   11,595  22,612   21,228Non-interest expense:               Salaries and employee benefits  39,781   39,593   36,218  79,374   71,869Severance  454   102   136  556   212Occupancy and equipment  7,899   8,209   7,729  16,108   15,731Data processing costs  5,151   5,423   4,903  10,574   9,697Marketing  1,951   2,025   1,756  3,976   3,422Professional services  2,325   1,909   2,097  4,234   4,213Federal deposit insurance premiums  1,712   1,266   1,692  2,978   3,739Net loss (gain) on extinguishment of debt  2   (974)  —  (972)  —Loss due to pension settlement  —   —   —  —   7,231Amortization of other intangible assets  195   209   235  404   487Other  5,231   4,994   5,533  10,225   9,209Total non-interest expense  64,701   62,756   60,299  127,457   125,810Income before taxes  47,876   48,528   40,172  96,404   68,881Income tax expense  13,062   13,946   10,475  27,008   17,726Net income  34,814   34,582   29,697  69,396   51,155Preferred stock dividends  1,821   1,822   1,821  3,643   3,643Net income available to common stockholders $32,993  $32,760  $27,876 $65,753  $47,512 DIME COMMERCIAL BANCSHARES, INC. AND SUBSIDIARIES
UNAUDITED COMMON SHARE DATA
(Dollars in thousands except per share amounts)                  Three Months Ended Six Months EndedGAAP June 30, 2026 March 31, 2026 June 30, 2025 June 30, 2026 June 30, 2025Net income available to common stockholders $32,993  $32,760  $27,876  $65,753  $47,512 Less: Dividends paid and earnings allocated to participating securities  (687)  (593)  (516)  (1,280)  (830)Income attributable to common stock - Basic and Diluted $32,306  $32,167  $27,360   64,473   46,682                 Weighted-average common shares outstanding  43,218,619   43,109,118   43,030,023   43,164,171   42,989,581                 Basic and diluted earnings per share ("EPS")(1) $0.75  $0.75  $0.64  $1.49  $1.09                 Non-GAAP            Adjusted net income available to common stockholders(2) $34,663  $32,405  $27,863  $67,068  $52,551 Less: Dividends paid and earnings allocated to participating securities  (722)  (586)  (516)  (1,308)  (910)Adjusted income attributable to common stock - Basic and Diluted $33,941  $31,819  $27,347  $65,760  $51,641                 Weighted-average common shares outstanding  43,218,619   43,109,118   43,030,023   43,164,171   42,989,581                 Adjusted basic and diluted EPS(3) $0.79  $0.74  $0.64  $1.52  $1.20  (1)The earnings per share is calculated by dividing income attributable to common stock by weighted-average common shares outstanding.(2)See "Non-GAAP Reconciliation" tables for reconciliation of reported and adjusted (non-GAAP) net income available to common stockholders.(3)The adjusted earnings per share is calculated by dividing adjusted income attributable to common stock by weighted-average common shares outstanding. DIME COMMERCIAL BANCSHARES, INC. AND SUBSIDIARIES
UNAUDITED SELECTED FINANCIAL HIGHLIGHTS
(Dollars in thousands except per share amounts)                   At or For the Three Months Ended At or For the Six Months Ended   June 30, March 31, June 30, June 30, June 30,   2026 2026 2025 2026 2025 Per Share Data:                Reported EPS (Diluted) $0.75 $0.75 $0.64 $1.49 $1.09 Cash dividends paid per common share  0.25  0.25  0.25  0.50  0.50 Book value per common share  31.79  31.33  29.95  31.79  29.95 Tangible common book value per share(1)  28.21  27.73  26.32  28.21  26.32 Common shares outstanding  44,158  44,057  43,889  44,158  43,889 Dividend payout ratio  33.33% 33.33% 39.06% 33.56% 45.87%                 Performance Ratios (Based upon Reported Net Income):                Return on average assets  0.94% 0.92% 0.85% 0.93% 0.74%Return on average equity  9.15  9.20  8.28  9.17  7.16 Return on average tangible common equity(1)  10.62  10.72  9.68  10.67  8.30 Net interest margin  3.28  3.21  2.98  3.24  2.96 Non-interest expense to average assets  1.74  1.68  1.72  1.71  1.81 Efficiency ratio  51.2  50.8  55.0  51.0  58.9 Effective tax rate  27.28  28.74  26.08  28.02  25.73                  Balance Sheet Data:                Average assets $14,862,346 $14,981,498 $14,013,592 $14,921,593 $13,896,281 Average interest-earning assets  14,086,464  14,202,286  13,195,116  14,144,055  13,079,859 Average tangible common equity(1)  1,247,394  1,228,003  1,158,738  1,237,751  1,152,361 Loan-to-deposit ratio at end of period(2)  84.4% 84.2% 92.6% 84.4% 92.6%                 Capital Ratios and Reserves - Consolidated:                Tangible common equity to tangible assets(1) (3)  8.37% 8.23% 8.22%      Tangible equity to tangible assets(1) (3)  9.15  9.02  9.05       Tier 1 common equity ratio(3)  11.99  11.87  11.25       Tier 1 risk-based capital ratio(3)  13.09  12.97  12.34       Total risk-based capital ratio(3)  16.30  16.17  15.84       Tier 1 leverage ratio(3)  9.46  9.24  9.43       Consolidated CRE concentration ratio(3)(4)  352  371  425       Allowance for credit losses/ Total loans  0.98  0.95  0.86       Allowance for credit losses/ Non-performing loans held for investment  157.09  176.20  175.12        (1)See "Non-GAAP Reconciliation" tables for reconciliation of tangible equity, tangible common equity, and tangible assets.(2)Total deposits include mortgage escrow deposits, which fluctuate seasonally.(3)June 30, 2026 ratios are preliminary pending completion and filing of the Company’s regulatory reports.(4)The Consolidated CRE concentration ratio is calculated using the sum of commercial real estate, excluding owner-occupied commercial real estate, multifamily, and acquisition, development, and construction, divided by consolidated capital. The June 30, 2026 ratio is preliminary pending completion and filing of the Company’s regulatory reports. DIME COMMERCIAL BANCSHARES, INC. AND SUBSIDIARIES
UNAUDITED AVERAGE BALANCES AND NET INTEREST INCOME
(Dollars in thousands)                            Three Months Ended   June 30, 2026 March 31, 2026 June 30, 2025         Average       Average       Average   Average    Yield/ Average    Yield/ Average    Yield/   Balance Interest Cost Balance Interest Cost Balance Interest Cost Assets:                         Interest-earning assets:                         Business loans $3,489,614 $56,520 6.50%$3,274,659 $52,406 6.49%$2,798,899 $46,593 6.68%One-to-four family residential and coop/condo apartment  1,064,043  12,588 4.75  1,041,802  12,383 4.82  981,138  11,532 4.71 Multifamily residential and residential mixed-use  3,195,372  35,930 4.51  3,363,792  37,698 4.55  3,740,939  42,462 4.55 Non-owner-occupied commercial real estate  2,815,624  37,117 5.29  2,910,973  37,497 5.22  3,175,062  41,822 5.28 Acquisition, development, and construction  90,738  1,711 7.56  106,808  2,079 7.89  136,154  3,009 8.86 Other loans  8,580  26 1.22  8,329  27 1.31  7,135  30 1.69 Total loans  10,663,971  143,892 5.41  10,706,363  142,090 5.38  10,839,327  145,448 5.38 Securities  1,582,300  14,518 3.68  1,451,425  12,788 3.57  1,361,383  11,353 3.34 Other short-term investments  1,840,193  16,840 3.67  2,044,498  18,522 3.67  994,406  10,749 4.34 Total interest-earning assets  14,086,464  175,250 4.99% 14,202,286  173,400 4.95% 13,195,116  167,550 5.09%Non-interest-earning assets  775,882       779,212       818,476      Total assets $14,862,346      $14,981,498      $14,013,592                                Liabilities and Stockholders' Equity:                         Interest-bearing liabilities:                         Interest-bearing checking(1) $1,040,981 $4,058 1.56%$1,133,722 $4,793 1.71%$943,716 $4,141 1.76%Money market  4,796,008  30,049 2.51  4,761,610  28,801 2.45  4,174,694  32,818 3.15 Savings(1)  1,684,130  9,826 2.34  1,742,334  10,042 2.34  1,925,224  14,048 2.93 Certificates of deposit  1,075,789  8,238 3.07  1,105,241  8,728 3.20  1,075,729  9,174 3.42 Total interest-bearing deposits  8,596,908  52,171 2.43  8,742,907  52,364 2.43  8,119,363  60,181 2.97 FHLBNY advances  418,517  3,541 3.39  479,534  3,850 3.26  508,000  4,053 3.20 Subordinated debt, net  231,102  3,810 6.61  271,596  4,449 6.64  272,385  4,301 6.33 Other short-term borrowings  —  — —  122  1 3.32  —  — — Total borrowings  649,619  7,351 4.54  751,252  8,300 4.48  780,385  8,354 4.29 Derivative cash collateral  62,134  542 3.50  52,708  485 3.73  79,188  918 4.65 Total interest-bearing liabilities  9,308,661  60,064 2.59% 9,546,867  61,149 2.60% 8,978,936  69,453 3.10%Non-interest-bearing checking(1)  3,864,575       3,747,722       3,412,215      Other non-interest-bearing liabilities  166,688       183,678       187,774      Total liabilities  13,339,924       13,478,267       12,578,925      Stockholders' equity  1,522,422       1,503,231       1,434,667      Total liabilities and stockholders' equity $14,862,346      $14,981,498      $14,013,592      Net interest income    $115,186      $112,251      $98,097   Net interest rate spread       2.40%      2.35%      1.99%Net interest margin       3.28%      3.21%      2.98%Deposits (including non-interest-bearing checking accounts)(1) $12,461,483 $52,171 1.68%$12,490,629 $52,364 1.70%$11,531,578 $60,181 2.09% (1)Includes mortgage escrow deposits. DIME COMMERCIAL BANCSHARES, INC. AND SUBSIDIARIES
UNAUDITED SCHEDULE OF NON-PERFORMING ASSETS
(Dollars in thousands)            At or For the Three Months Ended  June 30, March 31, June 30,Asset Quality Detail 2026  2026  2025 Non-performing loans held for investment ("NPLs")         Business loans $23,898  $24,257  $18,007 One-to-four family residential and coop/condo apartment  4,465   4,088   1,642 Multifamily residential and residential mixed-use  26,893   —   — Non-owner-occupied commercial real estate  11,151   28,368   32,908 Acquisition, development, and construction  412   412   657 Other loans  —   11   — Non-accrual loans held for investment $66,819  $57,136  $53,214 Non-accrual loans held for investment / Total loans held for investment  0.62%  0.54%  0.49%          Non-accrual loans held for sale $1,750  $38,000  $— Total non-accrual loans $68,569  $95,136  $53,214 Total non-accrual loans/ Total loans  0.64%  0.89%  0.49%          Total non-performing assets ("NPAs")(1) $69,019  $95,586  $53,214           Total loans 90 days delinquent and accruing ("90+ Delinquent") $—  $—  $—           NPAs and 90+ Delinquent $69,019  $95,586  $53,214           NPAs and 90+ Delinquent / Total assets  0.46%  0.64%  0.37%          Net loan charge-offs ("NCOs") $9,662  $8,574  $5,405 NCOs / Average loans(2)  0.36%  0.32%  0.20% (1)June 30, 2026 and March 31, 2026 balances include one non-performing available-for-sale security in the amount of $450 thousand.(2)Calculated based on annualized NCOs to average loans. DIME COMMERCIAL BANCSHARES, INC. AND SUBSIDIARIES
NON-GAAP RECONCILIATION
(Dollars in thousands except per share amounts)

The following tables below provide a reconciliation of certain financial measures calculated under generally accepted accounting principles ("GAAP") (as reported) and non-GAAP measures. A non-GAAP financial measure is a numerical measure of historical or future financial performance, financial position or cash flows that excludes or includes amounts that are required to be disclosed in the most directly comparable measure calculated and presented in accordance with GAAP in the United States. The Company’s management believes the presentation of non-GAAP financial measures provides investors with a greater understanding of the Company’s operating results in addition to the results measured in accordance with GAAP. While management uses these non-GAAP measures in its analysis of the Company’s performance, this information should not be viewed as a substitute for financial results determined in accordance with GAAP or considered to be more important than financial results determined in accordance with GAAP.

The following non-GAAP financial measures exclude pre-tax income and expenses associated with the fair value change in equity securities and loans held for sale, loss (gain) on sale of securities, loans and other assets, severance, net loss (gain) on extinguishment of debt and loss due to pension settlement.

                   Three Months Ended Six Months Ended   June 30, March 31, June 30, June 30, June 30,   2026  2026  2025  2026  2025  Reconciliation of Reported and Adjusted (non-GAAP) Net Income Available to Common Stockholders                Reported net income available to common stockholders $32,993  $32,760  $27,876  $65,753  $47,512  Adjustments to net income(1):                Fair value change in equity securities and loans held for sale  (38)  38   (83)  —   (101) Loss (gain) on sale of securities, loans and other assets  2,000   320   (72)  2,320   (72) Severance  454   102   136   556   212  Net loss (gain) on extinguishment of debt  2   (974)  —   (972)  —  Loss due to pension settlement  —   —   —   —   7,231  Income tax effect of adjustments noted above(1)  (748)  159   6   (589)  (2,231) Adjusted net income available to common stockholders (non-GAAP) $34,663  $32,405  $27,863  $67,068  $52,551                   Adjusted Ratios (Based upon Adjusted (non-GAAP) Net Income as calculated above)                Adjusted EPS (Diluted) $0.79  $0.74  $0.64  $1.52  $1.20  Adjusted return on average assets  0.98 % 0.91 % 0.85 % 0.95 % 0.81 %Adjusted return on average equity  9.59   9.11   8.28   9.35   7.87  Adjusted return on average tangible common equity  11.16   10.60   9.67   10.88   9.18  Adjusted non-interest expense to average assets  1.72   1.69   1.71   1.71   1.70  Adjusted efficiency ratio  49.9   51.2   54.7   50.5   55.2   (1)Adjustments to net income are taxed at the Company's approximate statutory tax rate.   The following table presents a reconciliation of operating expense as a percentage of average assets (as reported) and adjusted operating expense as a percentage of average assets (non-GAAP):

                  Three Months Ended  Six Months Ended  June 30,  March 31,  June 30,  June 30,  June 30,   2026   2026   2025   2026   2025  Operating expense as a % of average assets - as reported 1.74 % 1.68 % 1.72 % 1.71 % 1.81 %Severance (0.01)  —   —   (0.01)  —  Net loss (gain) on extinguishment of debt —   0.02   —   0.01   —  Loss due to pension settlement —   —   —   —   (0.10) Amortization of other intangible assets (0.01)  (0.01)  (0.01)  —   (0.01) Adjusted operating expense as a % of average assets (non-GAAP) 1.72 % 1.69 % 1.71 % 1.71 % 1.70 %                      The following table presents a reconciliation of efficiency ratio (non-GAAP) and adjusted efficiency ratio (non-GAAP):

                   Three Months Ended Six Months Ended   June 30, March 31, June 30, June 30, June 30,   2026  2026  2025  2026  2025  Efficiency ratio - as reported (non-GAAP)(1)  51.2 % 50.8 % 55.0 % 51.0 % 58.9 %Non-interest expense - as reported $64,701  $62,756  $60,299  $127,457  $125,810  Severance  (454)  (102)  (136)  (556)  (212) Net (loss) gain on extinguishment of debt  (2)  974   —   972   —  Loss due to pension settlement  —   —   —   —   (7,231) Amortization of other intangible assets  (195)  (209)  (235)  (404)  (487) Adjusted non-interest expense (non-GAAP) $64,050  $63,419  $59,928  $127,469  $117,880  Net interest income - as reported $115,186  $112,251  $98,097  $227,437  $192,310  Non-interest income - as reported $11,266  $11,346  $11,595  $22,612  $21,228  Fair value change in equity securities and loans held for sale  (38)  38   (83)  —   (101) Loss (gain) on sale of securities, loans and other assets  2,000   320   (72)  2,320   (72) Adjusted non-interest income (non-GAAP) $13,228  $11,704  $11,440  $24,932  $21,055  Adjusted total revenues for adjusted efficiency ratio (non-GAAP) $128,414  $123,955  $109,537  $252,369  $213,365  Adjusted efficiency ratio (non-GAAP)(2)  49.9 % 51.2 % 54.7 % 50.5 % 55.2 % (1)The reported efficiency ratio is a non-GAAP measure calculated by dividing GAAP non-interest expense by the sum of GAAP net interest income and GAAP non-interest income.(2)The adjusted efficiency ratio is a non-GAAP measure calculated by dividing adjusted non-interest expense by the sum of GAAP net interest income and adjusted non-interest income.   The following table presents a reconciliation of pre-tax pre provision net revenue (non-GAAP) and adjusted pre-tax pre-provision net revenue (non-GAAP):

                  Three Months Ended Six Months Ended  June 30, March 31, June 30, June 30, June 30,  2026 2026 2025 2026 2025Financial Data:               Net interest income $115,186 $112,251 $98,097 $227,437 $192,310Non-interest income  11,266  11,346  11,595  22,612  21,228Total revenue  126,452  123,597  109,692  250,049  213,538Non-interest expense  64,701  62,756  60,299  127,457  125,810Pre-tax pre-provision net revenue (non-GAAP)(1) $61,751 $60,841 $49,393 $122,592 $87,728Adjusted pre-tax pre-provision net revenue (non-GAAP)(2) $64,364 $60,536 $49,609 $124,900 $95,485 (1)The reported pre-tax pre-provision net revenue is a non-GAAP measure calculated by adding GAAP net interest income and GAAP non-interest income less GAAP non-interest expense.(2)The adjusted pre-tax pre-provision net revenue is a non-GAAP measure calculated by adding GAAP net interest income and the adjusted non-interest income less the adjusted non-interest expense as shown in the reconciliation of efficiency ratio table above.   The following table presents the tangible common equity to tangible assets, tangible equity to tangible assets, and tangible common book value per share calculations (non-GAAP):

             June 30, March 31, June 30,   2026  2026  2025  Reconciliation of Tangible Assets:          Total assets $15,042,953  $14,999,503  $14,207,935  Goodwill  (155,797)  (155,797)  (155,797) Other intangible assets  (2,534)  (2,729)  (3,409) Tangible assets (non-GAAP) $14,884,622  $14,840,977  $14,048,729             Reconciliation of Tangible Common Equity - Consolidated:          Total stockholders' equity $1,520,456  $1,496,970  $1,431,006  Goodwill  (155,797)  (155,797)  (155,797) Other intangible assets  (2,534)  (2,729)  (3,409) Tangible equity (non-GAAP)  1,362,125   1,338,444   1,271,800  Preferred stock, net  (116,569)  (116,569)  (116,569) Tangible common equity (non-GAAP) $1,245,556  $1,221,875  $1,155,231             Common shares outstanding  44,158   44,057   43,889             Tangible common equity to tangible assets (non-GAAP)  8.37 % 8.23 % 8.22 %Tangible equity to tangible assets (non-GAAP)  9.15   9.02   9.05             Book value per common share $31.79  $31.33  $29.95  Tangible common book value per share (non-GAAP)  28.21   27.73   26.32  

Česká národní banka by mohla podle Jana Kubíčka v nadcházejících měsících ještě jednou zvýšit úrokové sazby. Člen bankovní rady uvedl, že o této možnosti budou centrální bankéři pravděpodobně diskutovat už v srpnu. Důvod ke spěchu však zatím nevidí a tržní sázky na rychlý růst sazeb považuje za přehnané.

ČNB v červnu zvýšila svou hlavní repo sazbu o 25 bazických bodů. Šlo o první zpřísnění měnové politiky za poslední čtyři roky.

Kubíček uvedl, že při hodnocení potřeby dalšího růstu sazeb sleduje především vývoj úvěrů, jádrové inflace, růstu mezd, cen nemovitostí a také to, do jaké míry se vyšší dlouhodobé tržní sazby promítají do úroků z úvěrů.

Trh aktuálně prostřednictvím FRA kontraktů zaceňuje tři zvýšení sazeb o 25 bazických bodů do prvního čtvrtletí příštího roku. FRA kontrakty slouží k zajištění budoucích úrokových sazeb a běžně se využívají jako indikátor očekávání trhu ohledně dalšího vývoje měnové politiky. 

Takový výhled označil Kubíček za přehnaný. Zároveň však dodal, že by ho uklidnilo zpomalení růstu mezd a jádrové inflace. „Uklidnilo by mě také, kdybychom viděli zpomalování jádrové inflace. Čekáme na to už delší dobu a stále v to věříme. Velmi by mi pomohlo i to, kdybychom alespoň viděli konec zrychlování všech typů úvěrů,“ řekl Kubíček.

Podle něj zároveň existují známky toho, že růst cen nemovitostí začíná kulminovat. Také růst mezd by měl zpomalit po překvapivě silném meziročním nárůstu o 8,1 % v prvním čtvrtletí.

Banky byly podle něj dosud pod konkurenčním tlakem, který jim bránil plně promítat vyšší dlouhodobé sazby do hypotečních úvěrů. To se však nyní může začínat měnit.

Dalším faktorem, který ČNB sleduje, je vývoj firemních marží. Banka zkoumá, zda podniky nevyužívají vyšších nákladů k navyšování ziskovosti. Data za první čtvrtletí však podle Kubíčka nic takového nenaznačují.

Celková meziroční inflace v Česku v červnu překvapivě klesla na 1,5 %, především díky vývoji cen potravin. Ceny služeb, které ČNB pečlivě sleduje, však nadále rostly svižným tempem 4,5 %. Jádrová inflace činila 2,8 %.

Kubíček zároveň uvedl, že neočekává, že by nová prognóza ČNB, která bude zveřejněna příští měsíc, přinesla výrazně odlišný pohled na ekonomiku oproti květnové prognóze. Podle něj by byla centrální banka spokojena, pokud inflace na začátku příštího roku nepřekročí horní hranici tolerančního pásma, tedy 3 % kolem dvouprocentního inflačního cíle.

Silná náladovost trhu

Vývoj tržních očekávání zároveň ukazuje, jak obtížné je dnes odhadovat další kroky centrálních bank. To platí nejen pro ČNB, ale také pro americký Fed, jehož budoucí rozhodování investoři v posledních týdnech výrazně přehodnocují.

Podle dat společnosti CME Group aktuálně trh přisuzuje přibližně 34% pravděpodobnost zvýšení sazeb na červencovém zasedání Fedu. Před týdnem přitom tato pravděpodobnost činila pouze 12 %, zatímco na konci června dosahovala 36 %. Jen 14. července se očekávání trhu změnila o 14 procentních bodů během jediného dne.

— Hedgeye (@Hedgeye) July 22, 2026 Významnou roli v těchto změnách hraje nejistota spojená s vývojem cen ropy a dopady konfliktu na Blízkém východě. Dražší energie tlačí vzhůru inflační očekávání, výnosy dluhopisů i náklady domácností, což následně ovlivňuje očekávanou trajektorii úrokových sazeb.

Pro investory je tak aktuálně mimořádně obtížné odhadovat další kroky centrálních bank. Geopolitické události i obtížně předvídatelné kroky americké administrativy mohou tržní očekávání měnit doslova ze dne na den. Současné prostředí proto ukazuje, že investoři by se měli více soustředit na příchozí ekonomická data než na krátkodobé výkyvy tržních sázek.